<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Ear, nose and throat</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Gene therapy restores auditory function in deaf mice</title>
      <description>
        <![CDATA[DFNB16, a recessive form of mild-to-moderate human deafness, is caused by mutations in the <em>STRC</em> gene, which encodes stereocilin, a protein essential for the effective function of outer hair cells as cochlear amplifiers. Researchers from the Institut Pasteur and Sorbonne Université in Paris, France, have developed and evaluated the efficacy of an <em>Strc</em> gene therapy in a mouse model of DFNB16.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728436</guid>
      <pubDate>Fri, 30 Jan 2026 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728436-gene-therapy-restores-auditory-function-in-deaf-mice</link>
    </item>
    <item>
      <title>Seamless seals $1.12B gene editing deal with Lilly on hearing loss</title>
      <description>
        <![CDATA[Seamless Therapeutics has received big pharma endorsement of its proprietary recombinase gene editing platform, sealing a potential $1.12 billion deal with Eli Lilly and Co. to apply the technology in hearing loss.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728527</guid>
      <pubDate>Thu, 29 Jan 2026 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728527-seamless-seals-112b-gene-editing-deal-with-lilly-on-hearing-loss</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Ear-disorders.webp?t=1589216468" type="image/png" medium="image" fileSize="490074">
        <media:title type="plain">Ear illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Sensorion raises funding to advance SENS-601 into clinic</title>
      <description>
        <![CDATA[Sensorion SA has announced a €60 million (US$72 million) financing, with a €20 million (US$24 million) strategic investment from Sanofi SA, as it advances its pipeline of therapies to restore, treat and prevent hearing loss disorders.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728396</guid>
      <pubDate>Wed, 28 Jan 2026 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728396-sensorion-raises-funding-to-advance-sens-601-into-clinic</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Ear-and-sound-waves-illustration.webp?t=1616533957" type="image/png" medium="image" fileSize="319429">
        <media:title type="plain">Ear and sound waves illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>‘Most complete’ map of oral microbiome enables links to systemic disease</title>
      <description>
        <![CDATA[South Korean researchers led by Lee In-suk of Yonsei University have reported the most complete oral microbiome catalog to date, with more than 72,000 genomes. Detailed in <em>Cell Host & Microbe</em> on Nov. 12, 2025, the database is expected to serve as a universal platform for academia and enable “precision microbiome medicine” for the industry, Lee told <em>BioWorld.</em>]]>
      </description>
      <guid>http://www.bioworld.com/articles/726351</guid>
      <pubDate>Tue, 18 Nov 2025 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726351-most-complete-map-of-oral-microbiome-enables-links-to-systemic-disease</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/Nov-2020/Science-microbiome-11-5.webp?t=1604592414" type="image/png" medium="image" fileSize="553641">
        <media:title type="plain">Microbiome illustration</media:title>
        <media:description type="plain">Credit: Darryl Leja, NHGRI</media:description>
      </media:content>
    </item>
    <item>
      <title>‘Most complete’ map of oral microbiome enables links to systemic disease</title>
      <description>
        <![CDATA[South Korean researchers led by Lee In-suk of Yonsei University have reported the most complete oral microbiome catalog to date, with more than 72,000 genomes. Detailed in <em>Cell Host & Microbe</em> on Nov. 12, 2025, the database is expected to serve as a universal platform for academia and enable “precision microbiome medicine” for the industry, Lee told <em>BioWorld.</em>]]>
      </description>
      <guid>http://www.bioworld.com/articles/726031</guid>
      <pubDate>Thu, 13 Nov 2025 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726031-most-complete-map-of-oral-microbiome-enables-links-to-systemic-disease</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/Nov-2020/Science-microbiome-11-5.webp?t=1604592414" type="image/png" medium="image" fileSize="553641">
        <media:title type="plain">Microbiome illustration</media:title>
        <media:description type="plain">Credit: Darryl Leja, NHGRI</media:description>
      </media:content>
    </item>
    <item>
      <title>Novel antisense oligonucleotide therapy for DFNA2 hearing loss</title>
      <description>
        <![CDATA[Hearing loss is a major global health challenge, affecting over 5% of the population and largely lacking effective biological therapies. Mutations in KCNQ4, which encodes the Kv7.4 potassium channel essential for outer hair cell function, are a leading cause of autosomal dominant, non-syndromic hearing loss (DFNA2).]]>
      </description>
      <guid>http://www.bioworld.com/articles/724002</guid>
      <pubDate>Wed, 10 Sep 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724002-novel-antisense-oligonucleotide-therapy-for-dfna2-hearing-loss</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Inherited-genetic-hearing-loss.webp?t=1688999333" type="image/jpeg" medium="image" fileSize="205855">
        <media:title type="plain">Illustration of ear next to DNA double helix</media:title>
      </media:content>
    </item>
    <item>
      <title>Gene therapy rescues hearing loss in murine model of CLIC5 deafness</title>
      <description>
        <![CDATA[Adeno-associated virus (AAV)-based gene therapy is considered a promising strategy to treat hearing loss. However, its clinical application is limited by the genetic heterogeneity of hereditary hearing loss, requiring gene-specific analysis and approach optimization for broader treatment applications.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723880</guid>
      <pubDate>Thu, 04 Sep 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723880-gene-therapy-rescues-hearing-loss-in-murine-model-of-clic5-deafness</link>
    </item>
    <item>
      <title>Lineage enters collaboration for ANP-1 for hearing loss</title>
      <description>
        <![CDATA[Lineage Cell Therapeutics Inc. has entered into a research collaboration with William Demant Invest A/S to develop Lineage’s auditory neuronal cell transplant Resonance (ANP-1) for hearing loss.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723613</guid>
      <pubDate>Wed, 27 Aug 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723613-lineage-enters-collaboration-for-anp-1-for-hearing-loss</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Ear-anatomy.webp?t=1674747494" type="image/png" medium="image" fileSize="863347">
        <media:title type="plain">Illustration demonstrating parts of the ear</media:title>
      </media:content>
    </item>
    <item>
      <title>Turn on vitamin A pathway and regenerate an ear</title>
      <description>
        <![CDATA[Lizards, zebrafish, salamanders and tritons can regrow a tail, a fin, or even an entire limb after amputation. Cut a planarian into pieces, and you will end up with a bunch of them. Researchers at the National Institute of Biological Sciences in Beijing have discovered a genetic switch linked to vitamin A. After activating this pathway, they managed to regenerate the ear pinna of a mouse, an animal that previously lacked this ability.]]>
      </description>
      <guid>http://www.bioworld.com/articles/722041</guid>
      <pubDate>Tue, 08 Jul 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/722041-turn-on-vitamin-a-pathway-and-regenerate-an-ear</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/Lin-adp0176-hero.webp?t=1751381538" type="image/jpeg" medium="image" fileSize="1186724">
        <media:title type="plain">Aldh1a2 in rabbits vs. mice</media:title>
        <media:description type="plain">Aldh1a2 is highly expressed in rabbit blastema but not the mouse blastema. Credit: The Wei Wang Lab at National Institute of Biological Sciences, Beijing.</media:description>
      </media:content>
    </item>
    <item>
      <title>Turn on vitamin A pathway and regenerate an ear</title>
      <description>
        <![CDATA[Lizards, zebrafish, salamanders and tritons can regrow a tail, a fin, or even an entire limb after amputation. Cut a planarian into pieces, and you will end up with a bunch of them. Researchers at the National Institute of Biological Sciences in Beijing have discovered a genetic switch linked to vitamin A. After activating this pathway, they managed to regenerate the ear pinna of a mouse, an animal that previously lacked this ability.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721883</guid>
      <pubDate>Wed, 02 Jul 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721883-turn-on-vitamin-a-pathway-and-regenerate-an-ear</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/Lin-adp0176-hero.webp?t=1751381538" type="image/jpeg" medium="image" fileSize="1186724">
        <media:title type="plain">Aldh1a2 in rabbits vs. mice</media:title>
        <media:description type="plain">Aldh1a2 is highly expressed in rabbit blastema but not the mouse blastema. Credit: The Wei Wang Lab at National Institute of Biological Sciences, Beijing.</media:description>
      </media:content>
    </item>
    <item>
      <title>Turn on vitamin A pathway and regenerate an ear</title>
      <description>
        <![CDATA[Lizards, zebrafish, salamanders and tritons can regrow a tail, a fin, or even an entire limb after amputation. Cut a planarian into pieces, and you will end up with a bunch of them.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721629</guid>
      <pubDate>Tue, 01 Jul 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721629-turn-on-vitamin-a-pathway-and-regenerate-an-ear</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/Lin-adp0176-hero.webp?t=1751381538" type="image/jpeg" medium="image" fileSize="1186724">
        <media:title type="plain">Aldh1a2 in rabbits vs. mice</media:title>
        <media:description type="plain">Aldh1a2 is highly expressed in rabbit blastema but not the mouse blastema. Credit: The Wei Wang Lab at National Institute of Biological Sciences, Beijing.</media:description>
      </media:content>
    </item>
    <item>
      <title>GJB2-GT has specific targeting and efficacy in preclinical models of deafness</title>
      <description>
        <![CDATA[Pathogenic variants in the <em>GJB2</em> gene are the most common genetic cause of congenital sensorineural hearing loss and are mostly associated with an autosomal recessive non-syndromic deafness 1A (DFNB1A).]]>
      </description>
      <guid>http://www.bioworld.com/articles/718165</guid>
      <pubDate>Wed, 12 Mar 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/718165-gjb2-gt-has-specific-targeting-and-efficacy-in-preclinical-models-of-deafness</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Hearing-loss-illustration.webp?t=1738616487" type="image/jpeg" medium="image" fileSize="191144">
        <media:title type="plain">Hand cupping ear to illustration hearing loss</media:title>
      </media:content>
    </item>
    <item>
      <title>New animal model of eosinophilic otitis media developed</title>
      <description>
        <![CDATA[Eosinophilic otitis media (EOM) is a type 2-related otitis media. Scientists at the Hirosaki University Graduate School of Medicine have developed a new EOM animal model in guinea pigs by using the plant protease papain. Papin was intratympanically administered in a daily basis. They also investigated the expression of innate lymphoid cell type 2 (ILC2) in the middle ear mucosa of these animals.]]>
      </description>
      <guid>http://www.bioworld.com/articles/718052</guid>
      <pubDate>Mon, 10 Mar 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/718052-new-animal-model-of-eosinophilic-otitis-media-developed</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/ENT-ear-model-otoscope.webp?t=1741616070" type="image/jpeg" medium="image" fileSize="123407">
        <media:title type="plain">Anatomical model of the ear next to an otoscope</media:title>
      </media:content>
    </item>
    <item>
      <title>Researchers develop novel Kabuki syndrome murine model</title>
      <description>
        <![CDATA[Lysine demethylase 6A (KDM6A) is a demethylase that plays a key role at regulating developmental gene expression signatures in several tissues, including neuronal cells. The <em>KDM6A</em> gene is located in chromosome X and pathogenic variants in this gene are tied to Kabuki syndrome type 2. Even though progress in understanding the functions of KDM6A has been made, its role in cochlear development and auditory function remains poorly understood.]]>
      </description>
      <guid>http://www.bioworld.com/articles/718028</guid>
      <pubDate>Fri, 07 Mar 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/718028-researchers-develop-novel-kabuki-syndrome-murine-model</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/NIH-NHGRI-Mouse-ENCODE.webp?t=1670859742" type="image/png" medium="image" fileSize="1132276">
        <media:title type="plain">Mouse genome/DNA sequencing concept art.</media:title>
        <media:description type="plain">Credit: Darryl Leja, National Human Genome Research Institute, NIH</media:description>
      </media:content>
    </item>
    <item>
      <title>AC-102 penetrates rapidly, distributes evenly along the cochlea after intratympanic delivery in pigs</title>
      <description>
        <![CDATA[Researchers from Medical University of Vienna and affiliated organizations have presented findings from a study that aimed to assess the perilymph and tissue distribution of AC-102, a small and lipophilic intratympanically delivered pyridoindole derivative, in clinical development at Audiocure Pharma GmbH for the treatment of idiopathic sudden sensorineural hearing loss.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717577</guid>
      <pubDate>Wed, 05 Mar 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717577-ac-102-penetrates-rapidly-distributes-evenly-along-the-cochlea-after-intratympanic-delivery-in-pigs</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Ear-anatomy.webp?t=1674747494" type="image/png" medium="image" fileSize="863347">
        <media:title type="plain">Illustration demonstrating parts of the ear</media:title>
      </media:content>
    </item>
    <item>
      <title>GABARAP emerges as a therapeutic target to prevent aminoglycoside-induced hearing loss </title>
      <description>
        <![CDATA[Aminoglycoside antibiotics are essential for treating some severe bacterial infections but are notorious for causing irreversible hearing loss in 20%-47% of patients.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717539</guid>
      <pubDate>Mon, 03 Mar 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717539-gabarap-emerges-as-a-therapeutic-target-to-prevent-aminoglycoside-induced-hearing-loss</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/ear-hearing-loss.webp?t=1745258379" type="image/jpeg" medium="image" fileSize="268975">
        <media:title type="plain">Man holding hand up to ear</media:title>
      </media:content>
    </item>
    <item>
      <title>NS-101 restores synapse function in hearing loss models</title>
      <description>
        <![CDATA[Family with sequence similarity 19 member A5 (FAM19A5) is a secretory protein highly expressed in the brain that regulates synapse dynamics through its interaction with leucine-rich repeat-containing 4B (LRRC4B). Noise exposure is one of the most significant causes of synapse loss between inner hair cells and auditory nerve fibers, leading to a decline in hearing sensitivity.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717516</guid>
      <pubDate>Fri, 28 Feb 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717516-ns-101-restores-synapse-function-in-hearing-loss-models</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/ear-hearing-listen.webp?t=1589216536" type="image/png" medium="image" fileSize="164178">
        <media:title type="plain">Hearing ear icon</media:title>
      </media:content>
    </item>
    <item>
      <title>Restoring GJB2 expression rescues hereditary hearing loss</title>
      <description>
        <![CDATA[The most common form of hereditary deafness in humans is caused by mutations in the <em>GJB2</em> gene, which encodes the gap junction protein connexin 26. That regulates the transport of potassium and metabolites between inner ear cells. The coding sequence of this gene fits in an adenovirus-associated vector (AAV), making it an attractive approach for gene therapy.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717476</guid>
      <pubDate>Wed, 26 Feb 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717476-restoring-gjb2-expression-rescues-hereditary-hearing-loss</link>
    </item>
    <item>
      <title>Regeneron gene therapy improves children’s hearing</title>
      <description>
        <![CDATA[In Regeneron Pharmaceuticals Inc.’s phase I/II Chord study of 12 children with genetic hearing loss, 10 out of 11 have shown improvements after being treated with a gene therapy. “What is really remarkable about this type of therapeutic approach is that the first people who are going to see the impact are not actually the physicians – it’s the families,” Jonathon Whitton, vice president and Regeneron’s auditory global program head, told <em>BioWorld</em>.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717747</guid>
      <pubDate>Tue, 25 Feb 2025 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717747-regeneron-gene-therapy-improves-childrens-hearing</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Child-cupping-hand-to-ear.webp?t=1740523394" type="image/jpeg" medium="image" fileSize="137911">
        <media:title type="plain">Child cupping hand to ear</media:title>
      </media:content>
    </item>
    <item>
      <title>Loud and clear: Sound Pharma has phase III success in Meniere’s</title>
      <description>
        <![CDATA[Sound Pharmaceuticals Inc.’s lead candidate, the anti-inflammatory SPI-1005 (ebselen), has produced positive pivotal phase III study data in treating Meniere’s disease, an inner-ear disorder that can lead to vertigo and deafness.]]>
      </description>
      <guid>http://www.bioworld.com/articles/715257</guid>
      <pubDate>Wed, 11 Dec 2024 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/715257-loud-and-clear-sound-pharma-has-phase-iii-success-in-menieres</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Ear-disorders.webp?t=1589216468" type="image/png" medium="image" fileSize="490074">
        <media:title type="plain">Ear illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Ribox’s RXRG-001 cleared to enter clinic for radiation-induced xerostomia and hyposalivation</title>
      <description>
        <![CDATA[Ribox Therapeutics Ltd. has obtained IND clearance from the FDA for the company’s circular RNA therapy, RXRG-001.]]>
      </description>
      <guid>http://www.bioworld.com/articles/713887</guid>
      <pubDate>Mon, 28 Oct 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/713887-riboxs-rxrg-001-cleared-to-enter-clinic-for-radiation-induced-xerostomia-and-hyposalivation</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/RNA-strand.webp?t=1609964773" type="image/png" medium="image" fileSize="440899">
        <media:title type="plain">RNA strand</media:title>
      </media:content>
    </item>
    <item>
      <title>Antioxidants for hearing loss and Meniere’s disease disclosed in Primemupharma patent</title>
      <description>
        <![CDATA[Primemupharma Co. Ltd. has divulged compounds comprising a novel polyester linker acting as antioxidants reported to be useful for the treatment of hearing loss and Meniere’s disease.]]>
      </description>
      <guid>http://www.bioworld.com/articles/713473</guid>
      <pubDate>Tue, 15 Oct 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/713473-antioxidants-for-hearing-loss-and-menieres-disease-disclosed-in-primemupharma-patent</link>
    </item>
    <item>
      <title>New gene therapy for hereditary hearing loss described </title>
      <description>
        <![CDATA[More than half of all hearing loss cases are hereditary. Myelin protein zero-like 2, encoded by <em>MPZL2</em>, is widely expressed in cochlear cells in the inner ear. Mutations in <em>MPZL2</em> have been identified as the second most prevalent cause of mild to moderate hereditary hearing loss.]]>
      </description>
      <guid>http://www.bioworld.com/articles/713462</guid>
      <pubDate>Tue, 15 Oct 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/713462-new-gene-therapy-for-hereditary-hearing-loss-described</link>
    </item>
    <item>
      <title>Piplartine counteracts antibiotic-induced hearing loss</title>
      <description>
        <![CDATA[Piplartine, also called piperlongumine, had protective effects against hearing loss induced by aminoglycoside antibiotics in zebrafish and mouse models of kanamycin-induced hair cell loss. Kanamycin is a member of the aminoglycosides, a group of antibiotics that have broad-spectrum activity against gram-negative bacteria, including multidrug resistant strains.]]>
      </description>
      <guid>http://www.bioworld.com/articles/711468</guid>
      <pubDate>Tue, 13 Aug 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/711468-piplartine-counteracts-antibiotic-induced-hearing-loss</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/ear-hearing-loss.webp?t=1745258379" type="image/jpeg" medium="image" fileSize="268975">
        <media:title type="plain">Man holding hand up to ear</media:title>
      </media:content>
    </item>
    <item>
      <title>Mouse model of profound deafness linked to a &lt;em&gt;Cdh23&lt;/em&gt; variant </title>
      <description>
        <![CDATA[A spontaneous homozygous deletion affecting the copy number of the cadherin 23 (<em>Cdh23</em>) gene in a line of laboratory mice gave rise to a new murine model with hereditary hearing loss and vestibular alterations.]]>
      </description>
      <guid>http://www.bioworld.com/articles/711291</guid>
      <pubDate>Wed, 07 Aug 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/711291-mouse-model-of-profound-deafness-linked-to-a-emcdh23-em-variant</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/black-mouse-model.webp?t=1723042732" type="image/jpeg" medium="image" fileSize="172411">
        <media:title type="plain">Closeup of a mouse</media:title>
      </media:content>
    </item>
    <item>
      <title>Big pharma’s ear to the ground as hearing-loss drum beats louder</title>
      <description>
        <![CDATA[The primary-endpoint win by Sensorion SA in a phase II proof-of-concept study with SENS-401 (arazasetron) in hearing loss made public March 11 brought renewed interest in the space, where a number of players are advancing gene therapies. The story marches on, with Montpellier, France-based Sensorion due to discuss the product July 13 at the International Conference on Cochlear Implants and Other Implantable Technologies in Vancouver, British Columbia.]]>
      </description>
      <guid>http://www.bioworld.com/articles/710539</guid>
      <pubDate>Fri, 12 Jul 2024 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/710539-big-pharmas-ear-to-the-ground-as-hearing-loss-drum-beats-louder</link>
    </item>
    <item>
      <title>A gene therapy could restore hearing in adults </title>
      <description>
        <![CDATA[Patients with congenital hearing loss could benefit from a gene therapy currently in development. Although there are approaches that could reverse the process in children and young people before it becomes severe, so far, adults do not have any treatment that prevents the progressive deterioration of auditory sensory cells caused by this disease.]]>
      </description>
      <guid>http://www.bioworld.com/articles/710529</guid>
      <pubDate>Fri, 12 Jul 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/710529-a-gene-therapy-could-restore-hearing-in-adults</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Ear-anatomy.webp?t=1674747494" type="image/png" medium="image" fileSize="863347">
        <media:title type="plain">Illustration demonstrating parts of the ear</media:title>
      </media:content>
    </item>
    <item>
      <title>A gene therapy could restore hearing in adults </title>
      <description>
        <![CDATA[Patients with congenital hearing loss could benefit from a gene therapy currently in development. Although there are approaches that could reverse the process in children and young people before it becomes severe, so far, adults do not have any treatment that prevents the progressive deterioration of auditory sensory cells caused by this disease.]]>
      </description>
      <guid>http://www.bioworld.com/articles/710384</guid>
      <pubDate>Thu, 11 Jul 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/710384-a-gene-therapy-could-restore-hearing-in-adults</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Ear-anatomy.webp?t=1674747494" type="image/png" medium="image" fileSize="863347">
        <media:title type="plain">Illustration demonstrating parts of the ear</media:title>
      </media:content>
    </item>
    <item>
      <title>Shionogi enters option agreement for Cilcare’s hearing loss candidates</title>
      <description>
        <![CDATA[Shionogi & Co. Ltd. has entered into an option agreement with Cilcare Dev SAS to acquire the exclusive license for the global development, manufacturing and commercialization of hearing loss treatment drug candidates CIL-001 and/or CIL-003.]]>
      </description>
      <guid>http://www.bioworld.com/articles/709416</guid>
      <pubDate>Tue, 11 Jun 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/709416-shionogi-enters-option-agreement-for-cilcares-hearing-loss-candidates</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/ear-hearing-loss.webp?t=1745258379" type="image/jpeg" medium="image" fileSize="268975">
        <media:title type="plain">Man holding hand up to ear</media:title>
      </media:content>
    </item>
    <item>
      <title>DBX2 is a new gene tied to nonsyndromic hearing loss</title>
      <description>
        <![CDATA[It is known that >70% of the genes involved in pathogenic hearing loss are involved in autosomal recessive nonsyndromic hearing loss (ARNSHL), which accounts for 1 case for every 166 individuals in Iran due to the high rate of consanguineous marriage in the country.]]>
      </description>
      <guid>http://www.bioworld.com/articles/709365</guid>
      <pubDate>Tue, 11 Jun 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/709365-dbx2-is-a-new-gene-tied-to-nonsyndromic-hearing-loss</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Ear-and-sound-waves-illustration.webp?t=1616533957" type="image/png" medium="image" fileSize="319429">
        <media:title type="plain">Ear and sound waves illustration</media:title>
      </media:content>
    </item>
  </channel>
</rss>
